AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 165 filers reported holding AGIOS PHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is 0.31 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $200,655,000 | -57.1% | 3,900 | -51.2% | 0.04% | -53.9% |
| Q1 2017 | $467,200,000 | +20.4% | 8,000 | -14.0% | 0.09% | +18.7% |
| Q4 2016 | $388,089,000 | -23.5% | 9,300 | -3.1% | 0.08% | -15.7% |
| Q3 2016 | $507,072,000 | +33.0% | 9,600 | +5.5% | 0.09% | +34.8% |
| Q2 2016 | $381,245,000 | +6.7% | 9,100 | +3.4% | 0.07% | 0.0% |
| Q1 2016 | $357,280,000 | -37.5% | 8,800 | 0.0% | 0.07% | -32.7% |
| Q4 2015 | $571,296,000 | -66.4% | 8,800 | -63.5% | 0.10% | -56.1% |
| Q3 2015 | $1,701,219,000 | -49.6% | 24,100 | -20.7% | 0.22% | -40.7% |
| Q2 2015 | $3,378,656,000 | +17.9% | 30,400 | 0.0% | 0.38% | +18.2% |
| Q1 2015 | $2,866,720,000 | +9.8% | 30,400 | +30.5% | 0.32% | -5.9% |
| Q4 2014 | $2,610,532,000 | – | 23,300 | – | 0.34% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Caligan Partners LP | 514,711 | $22,194,338 | 5.19% |
| ACUTA CAPITAL PARTNERS, LLC | 78,700 | $3,393,544 | 2.86% |
| Bellevue Group AG | 3,879,548 | $167,286,110 | 2.72% |
| Parkman Healthcare Partners LLC | 446,416 | $19,249,458 | 2.58% |
| Eagle Health Investments LP | 330,830 | $14,265,390 | 2.50% |
| SECTOR GAMMA AS | 121,844 | $5,253,913 | 1.96% |
| Frazier Life Sciences Management, L.P. | 871,974 | $37,599,519 | 1.76% |
| BVF INC/IL | 1,190,107 | $51,317,414 | 1.44% |
| Rock Springs Capital Management LP | 1,044,261 | $45,028,534 | 1.36% |
| FARALLON CAPITAL MANAGEMENT LLC | 5,654,502 | $243,822,126 | 1.15% |